Optiscan Imaging (ASX:OIL) Research & Development: A$5.52 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:OIL Optiscan Imaging Ltd ASX:OIL
12 GF Score
Price A$0.14
! 3 Warning Signs
View Full Analysis

What is Optiscan Imaging Research & Development?

Optiscan Imaging ASX:OIL -6.67% 12 Research & Development is A$5.52 Mil as of Jun. 2026. GuruFocus rates ASX:OIL with a GF Score™ of 12/100. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Optiscan Imaging's Research & Development for the six months ended in Jun. 2026 was A$2.86 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 was A$5.52 Mil.

Optiscan Imaging  (ASX:OIL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Optiscan Imaging Research & Development Related Terms

Optiscan Imaging Research & Development Historical Data

* Premium members only.

The historical data trend for Optiscan Imaging's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Optiscan Imaging Research & Development Chart

Optiscan Imaging Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.17 2.44 3.90 5.46 6.28

Optiscan Imaging Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.11 2.55 2.91 2.66 2.86
ASX:OIL
12GF Score
Optiscan Imaging Ltd ASX:OIL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Optiscan Imaging Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$5.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of A$5.52 Mil mean?
Optiscan Imaging (ASX:OIL) has a Research & Development of A$5.52 Mil as of Jun. 2026. Research and development expense is the total cost for research and development activities. View historical data on Optiscan Imaging and its competitors.
Is Optiscan Imaging's Research & Development too high?
Optiscan Imaging's current Research & Development is A$5.52 Mil. Overall, Optiscan Imaging has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Optiscan Imaging's Research & Development compare to GRMN and COHR?
Optiscan Imaging's Research & Development of A$5.52 Mil can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Hardware company?
A good Research & Development depends on the Hardware industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Optiscan Imaging and its competitors. Optiscan Imaging's current Research & Development is A$5.52 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Optiscan Imaging stock overvalued right now?
Optiscan Imaging (ASX:OIL) has a current Research & Development of A$5.52 Mil. The current Research & Development is A$5.52 Mil. Optiscan Imaging's overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Optiscan Imaging (ASX:OIL), the current Research & Development is A$5.52 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Optiscan Imaging Business Description

Address 16 Miles Street, Mulgrave, Melbourne, VIC, AUS, 3170
Optiscan Imaging Ltd is engaged in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications. Its technology offers real-time, 3D, in vivo imaging at the single-cell level, in a non-destructive manner that enables clinicians to make immediate informed decisions. Its products include InVivage, ViewnVivo, and Customisation. Its geographical segments include Australia, Germany, Norway, China, and the United States.
12GF Score

Get the complete analysis for ASX:OIL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.14
Price